SCIENTIFIC PROGRAMME
SESSION I
HOW I TREAT
SMOLDERING MYELOMA
(SMM)
SESSION II
HOW I TREAT NEWLY
DIAGNOSED MULTIPLE
MYELOMA
SESSION III
FROM RISK
STRATIFICATION TO
RISK-BASED THERAPY?
DEBATE 1
SHOULD WE USE MRD
TESTING TO DETERMINE
THERAPY IN MULTIPLE
MYELOMA?
DEBATE 2
IS THERE A FUTURE ROLE
OF AUTOLOGOUS STEM
CELL TRANSPLANTATION?
SESSION IV
HOW I TREAT RELAPSED
MULTIPLE MYELOMA
DEBATE 3
SHOULD EVERY PATIENT
RECEIVE DARATUMUMAB
IN FIRST LINE?
ROUNDTABLE
MULTIPLE MYELOMA
FROM THE PERSPECTIVE
OF FDA/EMEA AND
FOUNDATIONS
SESSION V
YOU CAN’T BE IMMUNE
FOR IMMUNE THERAPY
ANYMORE
SESSION VI
OTHER PLASMA CELL
DYSCRASIAS
KEYNOTE LECTURES
THE FUTURE OF
MULTIPLE MYELOMA
SELECTED ABSTRACTS
FOR AN ORAL
PRESENTATION
ABSTRACTS SELECTED
AS POSTERS
DISCLOSURES
16:50-17:45 DEBATE 1 – Should we use MRD testing to determine therapy in multiple myeloma?
Chair: Ola Landgren (Miami)
16:50-16:55 Introduction Ola Landgren (Miami)
Audience votes YES or NO
16:55-17:10 YES Nikhil Munshi (Boston)
17:10-17:25 NO Angela Dispenzieri (Rochester)
17:25-17:45 Discussion
Audience votes again YES or NO
17:45-18:40 DEBATE 2 – Is there a future role of autologous stem cell transplantation?
Chair: Francesca Gay (Turin)
17:45-17:50 Introduction Francesca Gay (Turin)
Audience votes YES or NO
17:50-18:05 YES Salomon Manier (Lille)
18:05-18:20 NO Ola Landgren (Miami)
18:20-18:40 Discussion
Audience votes again YES or NO
18:50-19:50 3 Simultaneous Meet the Expert sessions
1. How to sequence therapy in RRMM Xavier Leleu (Poitiers) and
Inger Nijhof (Amsterdam)
2. How to prevent and treat side effects of immune therapy Niels van de Donk (Amsterdam) and
Nina Shah (San Francisco)
3. How to deal with small plasma cell clones leading Angela Dispenzieri (Rochester) and
to clinical symptoms Joan Blade (Barcelona)
Saturday, April 17, 2021
09:00-10:00 SATELLITE SYMPOSIUM
Management of Relapsed and Refractory Multiple Myeloma with novel monoclonal antibody-based
regimens - From evidence-based considerations to clinical practice
Chair: Hartmut Goldschmidt (Heidelberg)
Speakers: Philippe Moreau (Nantes), Kwee Yong (London), Sonja Zweegman (Amsterdam)
This symposium is organised and funded by Sanofi
10:00-10:10 Coffee break
3